Newswise Feature Channel: Parkinson’s Disease

Out-of-Pocket Costs Continue to Rise for Neurologic Medications

Ohio State University Wexner Medical Center — Thu, 31 Oct 2024 12:45:39 EST

Out-of-pocket costs continue to increase for patients who must buy commonly prescribed drugs to treat these five neurological diseases - epilepsy, multiple sclerosis (MS), peripheral neuropathy, Alzheimer's disease and Parkinson's disease. This is according to research published online in Neurology(r), the medical journal of the American Academy of Neurology.

Costs Still on the Rise for Drugs for Neurological Diseases

American Academy of Neurology (AAN) — Wed, 30 Oct 2024 16:00:00 EST

The amount of money people pay out-of-pocket for branded drugs to treat neurological diseases like multiple sclerosis (MS), Alzheimer's, and Parkinson's disease continues to rise, especially for MS drugs, according to a study published in the October 30, 2024, online issue of Neurology(r), the medical journal of the American Academy of Neurology.

Antibiotics and Antifungals May Slightly Affect Parkinson's Risk, Study Finds

Rutgers University-New Brunswick — Wed, 23 Oct 2024 12:15:52 EST

New research by Rutgers Health researchers highlights a complex relationship between bacteria in the digestive tract and brain health.

Speech Accessibility Project expands to Canada

Fri, 18 Oct 2024 10:55:22 EST

The Speech Accessibility Project is now recruiting Canadian adults with Parkinson's disease, cerebral palsy, amyotrophic lateral sclerosis, Down syndrome and those who have had a stroke.

Protein Shakeup: Researchers Uncover New Function of a Protein That May Unlock Age-Related Illnesses

McMaster University — Thu, 17 Oct 2024 20:35:42 EST

McMaster University researchers have discovered a previously unknown cell-protecting function of a protein, which could open new avenues for treating age-related diseases and lead to healthier aging overall.

High Flux Isotope Reactor a Fit for Nobel Laureate's Designer Proteins

Oak Ridge National Laboratory — Wed, 16 Oct 2024 15:45:27 EST

Biochemist David Baker -- just announced as a recipient of the Nobel Prize for Chemistry -- turned to the High Flux Isotope Reactor (HFIR) at Oak Ridge National Laboratory for information he couldn't get anywhere else. HFIR is the strongest reactor-based neutron source in the United States.

HLTH 2024: Cedars-Sinai Accelerator Hosts Demo Day

Cedars-Sinai — Wed, 16 Oct 2024 12:30:09 EST

Participants from the Cedars-Sinai Accelerator's 10th class are set to showcase their leading-edge healthcare solutions during Demo Day at HLTH 2024 on Tuesday, Oct. 22, from 2:30 p.m. to 4 p.m. at The Venetian Expo Center in Las Vegas, Nevada.

Challenging Current Understanding, Study Reveals Rapid Release of Dopamine Not Needed for Initiating Movement

Harvard Medical School — Wed, 16 Oct 2024 11:00:00 EST

At a glance: Study in mice reveals rapid release of dopamine is not needed for initiating movement but is important for activities related to reward-seeking and motivation. The findings help explain why the widely used Parkinson's drug levodopa improves movement-related symptoms but often fails to ameliorate some cognitive ones. The work may inform the development of new therapies that restore both slow and fast dopamine action to treat multiple symptoms.

Researchers Create 'Mini Brains' to Model Lewy Body Dementia and Pinpoint Treatments

Mayo Clinic — Tue, 15 Oct 2024 11:25:30 EST

Lewy body dementia (LBD) is a progressive neurodegenerative disease that shares traits with both Parkinson's disease and Alzheimer's disease but can be more difficult to diagnose. Symptoms can include hallucinations, movement disorders, cognitive issues, sleep problems and depression.

الباحثون يبتكرون "أدمغة مصغرة" لنمذجة خرف أجسام ليوي وتحديد العلاجات المناسبة

Mayo Clinic — Mon, 14 Oct 2024 14:15:13 EST

خرف أجسام ليوي هو مرض تنكسي عصبي متفاقم يشترك في بعض سماته مع داء باركينسون و داء الزهايمر، ولكنه قد يكون أكثر صعوبة في التشخيص. يمكن أن تشمل الأعراض الهلوسات واضطرابات الحركة ومشاكل في الإدراك واضطرابات النوم والاكتئاب.

Pesquisadores criam "minicerebros" para modelar a demencia por corpos de Lewy e identificar tratamentos

Mayo Clinic — Mon, 14 Oct 2024 13:55:00 EST

A demencia por corpos de Lewy (DCL) e uma doenca neurodegenerativa progressiva que compartilha caracteristicas tanto da doenca de Parkinson quanto da doenca de Alzheimer, mas que pode ser mais dificil de ser diagnosticada. Os sintomas podem incluir alucinacoes, disturbios do movimento, problemas cognitivos, problemas de sono e depressao.

Investigadores Crean "Minicerebros" Para Modelar La Demencia Con Cuerpos De Lewy E Identificar Tratamientos

Mayo Clinic — Mon, 14 Oct 2024 13:50:00 EST

La demencia con cuerpos de Lewy (DCL) es una enfermedad neurodegenerativa progresiva que comparte caracteristicas tanto de la enfermedad de Parkinson cuanto de la enfermedad de Alzheimer, pero que puede ser mas dificil de diagnosticar. Los sintomas pueden incluir alucinaciones, trastornos del movimiento, problemas cognitivos, problemas para dormir y depresion.

UC Irvine researchers are first to reveal role of ophthalmic acid in motor function control

University of California, Irvine — Fri, 04 Oct 2024 13:05:44 EST

A research team from the University of California, Irvine is the first to reveal that a molecule in the brain - ophthalmic acid - unexpectedly acts like a neurotransmitter similar to dopamine in regulating motor function, offering a new therapeutic target for Parkinson's and other movement diseases.

Department of Defense-Funded Research May Lead to Breakthroughs for Parkinson's Symptom Management

Binghamton University, State University of New York — Fri, 04 Oct 2024 10:05:09 EST

Binghamton University, State University of New York Psychology Professor Christopher R. Bishop is part of a collaborative research team that recently received a four-year grant from The Department of Defense to investigate the underlying cause of neuropsychiatric symptoms in Parkinson's disease.

October 2024 Issue of Neurosurgical Focus: Video: "Movement Disorders"

Journal of Neurosurgery — Tue, 01 Oct 2024 00:05:00 EST

Announcement of contents of the October 2024 issue of Neurosurgical Focus: Video

Automatic Speech Recognition Learned to Understand People with Parkinson's Disease -- by Listening to Them

Fri, 27 Sep 2024 11:05:03 EST

Listening to people with Parkinson's disease made an automatic speech recognizer 30% more accurate, according to initial findings from the Speech Accessibility Project. Speech recordings used in the study are freely available to organizations looking to improve their voice recognition devices.

Expert Available: Brett Favre Announces Parkinson's Disease Diagnosis

George Washington University — Thu, 26 Sep 2024 12:00:38 EST

Former NFL quarterback, Brett Favre announced this week he's been diagnosed with Parkinson's disease. He was diagnosed in January but announced it this week while testifying during a hearing on... ...

Florida Atlantic University Parkinson's Expert Available

Florida Atlantic University — Wed, 25 Sep 2024 23:05:38 EST

Mount Sinai Parkinson's Expert Available

Mount Sinai Health System — Wed, 25 Sep 2024 11:05:25 EST

Penny for Your Thoughts? Master Copper Regulator Discovery May Offer Alzheimer's Clues

Florida Atlantic University — Wed, 18 Sep 2024 08:30:03 EST

A groundbreaking study using a tiny roundworm could pave the way for new treatments for neurodegenerative disorders. Researchers have linked the worm gene swip-10 to copper regulation - a vital element for brain health found in everyday items like wiring and cookware. Understanding the roles of swip-10 and MBLAC1, a protein involved in processing cellular materials, could lead to the development of effective medications and opens new avenues for advancing brain disease treatments.